Assenagon Asset Management’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.73M | Buy |
325,030
+240,643
| +285% | +$1.28M | ﹤0.01% | 789 |
|
|
2025
Q1 | $749K | Sell |
84,387
-80,080
| -49% | -$710K | ﹤0.01% | 929 |
|
|
2024
Q4 | $2.25M | Sell |
164,467
-2,766
| -2% | -$37.9K | ﹤0.01% | 893 |
|
|
2024
Q3 | $4.58M | Sell |
167,233
-83,291
| -33% | -$2.28M | 0.01% | 718 |
|
|
2024
Q2 | $6.13M | Buy |
250,524
+52,813
| +27% | +$1.29M | 0.01% | 549 |
|
|
2024
Q1 | $4.22M | Buy |
197,711
+65,031
| +49% | +$1.39M | 0.01% | 621 |
|
|
2023
Q4 | $2.54M | Sell |
132,680
-143,541
| -52% | -$2.75M | 0.01% | 817 |
|
|
2023
Q3 | $4.43M | Buy |
276,221
+54,493
| +25% | +$874K | 0.01% | 586 |
|
|
2023
Q2 | $5.14M | Buy |
221,728
+110,743
| +100% | +$2.57M | 0.02% | 468 |
|
|
2023
Q1 | $2.58M | Buy |
110,985
+18,948
| +21% | +$440K | 0.01% | 728 |
|
|
2022
Q4 | $1.34M | Buy |
92,037
+79,652
| +643% | +$1.16M | ﹤0.01% | 921 |
|
|
2022
Q3 | $236K | Sell |
12,385
-31,750
| -72% | -$605K | ﹤0.01% | 1213 |
|
|
2022
Q2 | $802K | Buy |
44,135
+828
| +2% | +$15K | ﹤0.01% | 1093 |
|
|
2022
Q1 | $1.09M | Buy |
43,307
+12,064
| +39% | +$304K | ﹤0.01% | 1000 |
|
|
2021
Q4 | $862K | Buy |
+31,243
| New | +$862K | ﹤0.01% | 1031 |
|
|
2021
Q3 | – | Sell |
-18,036
| Closed | -$552K | – | 1344 |
|
|
2021
Q2 | $552K | Buy |
+18,036
| New | +$552K | ﹤0.01% | 994 |
|
|
2020
Q4 | – | Sell |
-465,843
| Closed | -$6.08M | – | 1131 |
|
|
2020
Q3 | $6.08M | Buy |
+465,843
| New | +$6.08M | 0.03% | 257 |
|